COMPOSITIONS CONTAINING AN ASSOCIATION OF ASPIRIN AND AN ANTI-XA OLIGOSACCHARIDE AND USE OF AN ANTI-XA OLIGOSACCHARIDE OPTIONALLY IN COMBINATION WITH ASPIRIN

The invention relates to the use of a synthetic oligosaccharide which is a selective inhibitor of factor Xa acting via antithrombin III, alone or in association with aspirin, for the preparation of medicaments intended for preventing or treating thromboembolic diseases occurring in a mammal which ha...

Full description

Saved in:
Bibliographic Details
Main Authors STIEKEMA, JACOBUS CHRISTIANUS JOHANNES, CARIOU, ROGER
Format Patent
LanguageEnglish
French
Published 08.05.2001
Edition6
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention relates to the use of a synthetic oligosaccharide which is a selective inhibitor of factor Xa acting via antithrombin III, alone or in association with aspirin, for the preparation of medicaments intended for preventing or treating thromboembolic diseases occurring in a mammal which has undergone a percutaneous transluminal angioplasty. The subject of the invention is moreover pharmaceutical compositions for the treatment or prophylaxy of thromboembolic diseases occurring in a mammal which has undergone a percutaneous transluminal angioplasty, comprising the association of an effective quantity of at least one synthetic oligosaccharide, which is a selective inhibitor of factor Xa acting via antithrombin III, and of an effective quantity of aspirin, optionally mixed with one or more pharmaceutically acceptable excipients.
Bibliography:Application Number: CA19972199642